Listijono Dave, Kilani Suha, Tilia Liza, Garrett Don, Chapman Michael
a School of Women and Children's Health, University of New South Wales , Sydney , Australia.
b Department of Embryology , IVFAustralia , Maroubra , Australia.
Hum Fertil (Camb). 2015;18(4):234-7. doi: 10.3109/14647273.2015.1038658. Epub 2015 May 22.
To reduce patient inconvenience during in vitro fertilization (IVF) cycles, some protocols delay intensive monitoring until mid-follicular stimulation. Others assess hormone levels prior to follicle-stimulating hormone (FSH) administration, not commencing stimulation until baseline progesterone (P4) levels (< 5 nmol/l) are achieved. Higher P4 levels (> 4.8 nmol/L) on the day of FSH trigger have been implicated in poorer pregnancy rates. This study evaluates the association of P4 levels at day 1-2 in gonadotrophin-releasing hormone (GnRH)-antagonist cycles with pre-trigger P4 levels and clinical pregnancy rates (CPRs).
All fresh GnRH-antagonist IVF cycles between June 2011 and June 2012, in which pre-FSH P4 levels were not routinely performed (group 1), were retrieved from the IVF Australia database and compared with controls (group 2).
There were 163 cycles in each group. P4 levels on the day of trigger were significantly higher in group 1 (3.75 vs. 2.77, p < 0.05). The incidence of pre-trigger P4 levels >4.8 nmol/l was significantly higher in group 1 (30 vs. 16, p < 0.05). The number of oocytes retrieved was higher in group 1 (11.1 vs. 9, p < 0.05), however fertilization rates were significantly lower in that group (53.6% vs. 61.2%, p < 0.05); CPRs were similar between the two groups (27.8% vs. 31.8%, p = ns). Overall, pregnancy rates were lower in cycles with pre-trigger P4 level of > 4.8 nmol/L compared with those with lower levels (15% vs. 32.5%, p < 0.05).
We found that measurement of P4 level at early follicular phase was associated with significantly lower pre-trigger levels. However, this did not translate into a difference in CPR between the monitored and unmonitored groups. We have confirmed that elevation in pre-trigger P4 level is associated with halving of the CPR, indicating that the most important P4 measurements are those in the late follicular/pre-trigger phase.
为减少体外受精(IVF)周期中患者的不便,一些方案将密集监测推迟至卵泡刺激中期。另一些方案则在注射促卵泡激素(FSH)之前评估激素水平,直到达到基线孕酮(P4)水平(<5 nmol/l)才开始刺激。FSH触发日P4水平较高(>4.8 nmol/L)与较低的妊娠率有关。本研究评估在促性腺激素释放激素(GnRH)拮抗剂周期中第1 - 2天的P4水平与触发前P4水平及临床妊娠率(CPR)之间的关联。
从澳大利亚IVF数据库中检索2011年6月至2012年6月期间所有未常规检测FSH前P4水平的新鲜GnRH拮抗剂IVF周期(第1组),并与对照组(第2组)进行比较。
每组各有163个周期。第1组触发日的P4水平显著更高(3.75对2.77,p<0.05)。第1组触发前P4水平>4.8 nmol/l的发生率显著更高(30对16,p<0.05)。第1组获取的卵母细胞数量更多(11.1对9,p<0.05),然而该组的受精率显著更低(53.6%对61.2%,p<0.05);两组的临床妊娠率相似(27.8%对31.8%,p =无显著差异)。总体而言,触发前P4水平>4.8 nmol/L的周期与较低水平的周期相比,妊娠率更低(15%对32.5%,p<0.05)。
我们发现卵泡早期P4水平的检测与触发前水平显著降低有关。然而,这并未转化为监测组与未监测组之间临床妊娠率的差异。我们已证实触发前P4水平升高与临床妊娠率减半有关,表明最重要的P4测量是在卵泡晚期/触发前阶段。